Ovarian function and reproductive outcome after ovarian tissue transplantation: a systematic review.


Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
29 11 2019
Historique:
received: 08 08 2019
accepted: 19 11 2019
entrez: 1 12 2019
pubmed: 1 12 2019
medline: 17 9 2020
Statut: epublish

Résumé

The aim of this systematic review study is to summarize the current knowledge of ovarian tissue transplantation and provide insight on ovarian function, fertility and reproductive outcome following ovarian tissue transplantation. Relevant studies were identified by searching through PubMed, Cochrane Library, Embase, ProQuest, and Scopus databases until August 2018. Ovarian function by examination of the hormonal level was evaluated, together with follicular growth, the return of menstrual cycle and assessment of reproductive consequences: pregnancy, miscarriage rates and live birth after transplantation. Studies including female patients aged between 22 and 49 years that were subjected to ovarian tissue transplantation were considered. A total of 1185 studies were identified in the primary search. Titles and abstracts were screened for assessment of the inclusion criteria. Finally, twenty-five articles met the criteria and were included in this study. In general, 70% of patients that underwent ovarian tissue transplantation had ovarian and endocrine function restoration as well as follicular growth. Pregnancy was reported with 52% of the patients. The available evidence suggests that ovarian tissue transplantation is a useful and an applied approach to restore hormonal function, endocrine balance and eventually fertility outcomes in patients that are predisposed to lose their fertility, diagnosed with premature ovarian failure (POF), as well as women undergoing cancer treatments. Identification of the techniques with the lowest invasions for follicular and oocyte development after ovarian tissue transplantation aiming to reduce probable adverse effects after treatment is indispensable.

Identifiants

pubmed: 31783875
doi: 10.1186/s12967-019-02149-2
pii: 10.1186/s12967-019-02149-2
pmc: PMC6883646
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

396

Références

Nature. 2004 Mar 11;428(6979):137-8
pubmed: 15014485
Endocrinol Metab Clin North Am. 1998 Dec;27(4):927-43
pubmed: 9922915
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Gynecol Endocrinol. 2018 Jul;34(7):558-562
pubmed: 29318892
Hum Reprod. 2006 Aug;21(8):2010-4
pubmed: 16585122
Fertil Steril. 2011 Feb;95(2):804.e7-10
pubmed: 20801441
Lancet. 2004 Oct 16-22;364(9443):1405-10
pubmed: 15488215
J Minim Invasive Gynecol. 2017 Sep - Oct;24(6):897-898
pubmed: 28274872
J Clin Endocrinol Metab. 2011 Apr;96(4):1136-44
pubmed: 21289248
Acta Obstet Gynecol Scand. 2005 Jul;84(7):695-8
pubmed: 15954881
Hum Reprod. 2014 Sep;29(9):1931-40
pubmed: 24958067
BMC Med. 2016 Jan 04;14:1
pubmed: 26728489
Med J Aust. 2013 Feb 18;198(3):158-9
pubmed: 23418697
Hum Reprod. 1996 Aug;11(8):1668-73
pubmed: 8921114
Future Oncol. 2014 Mar;10(4):549-61
pubmed: 24754587
Biomed Res Int. 2014;2014:307268
pubmed: 24779007
Hum Reprod. 2015 Dec;30(12):2838-45
pubmed: 26443605
Minerva Ginecol. 2018 Aug;70(4):432-435
pubmed: 29696941
Reprod Biomed Online. 2015 Jun;30(6):643-50
pubmed: 25892498
J Clin Endocrinol Metab. 2001 Sep;86(9):4489-94
pubmed: 11549698
Acta Obstet Gynecol Scand. 2015 Sep;94(9):937-41
pubmed: 26095872
Fertil Steril. 2013 Jan;99(1):227-30
pubmed: 23102860
Dtsch Arztebl Int. 2012 Jan;109(1-2):8-13
pubmed: 22282711
Maturitas. 2010 Feb;65(2):161-6
pubmed: 19733988
Cancer. 2011 Jan 1;117(1):4-10
pubmed: 21235031
Reprod Biomed Online. 2016 Mar;32(3):334-6
pubmed: 26776823
Fertil Steril. 2010 Nov;94(6):2191-6
pubmed: 20171622
Hum Reprod. 2010 Oct;25(10):2489-95
pubmed: 20663793
Hum Reprod. 2015 Mar;30(3):608-15
pubmed: 25567618
Leuk Lymphoma. 2007 Aug;48(8):1569-76
pubmed: 17701589
Hum Reprod. 2010 May;25(5):1280-1
pubmed: 20172869
Ann Med. 2011;43(6):437-50
pubmed: 21226660
Dtsch Arztebl Int. 2008 Apr;105(15):274-8
pubmed: 19629232
Fertil Steril. 2000 Mar;73(3):599-603
pubmed: 10689020
Fertil Steril. 2012 Feb;97(2):387-90
pubmed: 22177311
Hum Reprod. 2015 Sep;30(9):2107-9
pubmed: 26062556
Sci Rep. 2017 Aug 17;7(1):8538
pubmed: 28819292
Arch Gynecol Obstet. 2015 Feb;291(2):419-26
pubmed: 25115279
Ann Med Health Sci Res. 2013 Jan;3(1):90-5
pubmed: 23634337
Bone Marrow Transplant. 2015 Sep;50(9):1206-11
pubmed: 25961773
Fertil Steril. 2015 Feb;103(2):462-8
pubmed: 25487750
Reproduction. 2008 Dec;136(6):681-9
pubmed: 18682546
Fertil Steril. 2016 Aug;106(2):467-74
pubmed: 27181924
Arch Gynecol Obstet. 2017 Apr;295(4):1033-1039
pubmed: 28197717
J Assist Reprod Genet. 2012 Jun;29(6):489-93
pubmed: 22492223
Fertil Steril. 2009 Apr;91(4 Suppl):1503-6
pubmed: 18930206

Auteurs

Sepideh Sheshpari (S)

Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, 5166615739, Iran.

Mahnaz Shahnazi (M)

Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, 5166615739, Iran.

Halimeh Mobarak (H)

Department of Clinical Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, 9177948974, Iran.

Shahin Ahmadian (S)

Department of Biology, Faculty of Science, Azerbaijan Shahid Madani University, Tabriz, 537517169, Iran.

Alberto Miranda Bedate (AM)

Laboratory for Translational Immunology (LTI), Universitair Medisch Centrum Utrecht, (UMCU), Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Ziba Nariman-Saleh-Fam (Z)

Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, 5166615739, Iran.

Mohammad Nouri (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, 5166615739, Iran.
Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Daneshgah St., Tabriz, 5166615739, Iran.

Reza Rahbarghazi (R)

Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, 5166615739, Iran.
Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, 5166615739, Iran.

Mahdi Mahdipour (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, 5166615739, Iran. mahdipourm@tbzmed.ac.ir.
Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Daneshgah St., Tabriz, 5166615739, Iran. mahdipourm@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH